
Disruptive Technology Channel
Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure.
Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure.